Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Falcoff

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?F Sigaux, S Castaigne, P Lehn, et al.
Bulletin Du Cancer|January 1, 1984
[Phase-1 study of the tolerance for increasing doses of recombinant human alpha 2 interferon in patients with advanced cancer]B Bretaudeau, T Palangie, E Giralt, et al.
The Journal of Infectious Diseases|March 1, 1984
Endogenous interferon in Argentine hemorrhagic feverS C Levis, M C Saavedra, C Ceccoli, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1973
Double-stranded ribonucleic acid from Mengo virus: production, characterization, and interferon-inducing and antiviral activities in comparison with polyriboinosinic-polyribocytidylic acidE Falcoff, R Falcoff, J Cherby, et al.
Leukemia Research|January 1, 1991
Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patientsC Billard, D Ferbus, R A Diez, et al.
Microbiology and Immunology|January 1, 1995
Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gammaS Revelli, H Davila, M E Ferro, et al.
The New England Journal of Medicine|January 4, 1990
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gammaR Badaro, E Falcoff, F S Badaro, et al.
The Journal of Infectious Diseases|April 1, 1991
Tumor necrosis factor (cachectin) in human visceral leishmaniasisM Barral-Netto, R Badaró, A Barral, et al.
Acta Tropica|February 1, 1996
In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensisM Barral-Netto, R L Von Sohsten, M Teixeira, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1994
Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compoundsE Falcoff, N J Taranto, C E Remondegui, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?F Sigaux, S Castaigne, P Lehn, et al.
Bulletin Du Cancer|January 1, 1984
[Phase-1 study of the tolerance for increasing doses of recombinant human alpha 2 interferon in patients with advanced cancer]B Bretaudeau, T Palangie, E Giralt, et al.
The Journal of Infectious Diseases|March 1, 1984
Endogenous interferon in Argentine hemorrhagic feverS C Levis, M C Saavedra, C Ceccoli, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1973
Double-stranded ribonucleic acid from Mengo virus: production, characterization, and interferon-inducing and antiviral activities in comparison with polyriboinosinic-polyribocytidylic acidE Falcoff, R Falcoff, J Cherby, et al.
Leukemia Research|January 1, 1991
Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patientsC Billard, D Ferbus, R A Diez, et al.
Microbiology and Immunology|January 1, 1995
Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gammaS Revelli, H Davila, M E Ferro, et al.
The New England Journal of Medicine|January 4, 1990
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gammaR Badaro, E Falcoff, F S Badaro, et al.
The Journal of Infectious Diseases|April 1, 1991
Tumor necrosis factor (cachectin) in human visceral leishmaniasisM Barral-Netto, R Badaró, A Barral, et al.
Acta Tropica|February 1, 1996
In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensisM Barral-Netto, R L Von Sohsten, M Teixeira, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1994
Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compoundsE Falcoff, N J Taranto, C E Remondegui, et al.
Pageof 6